Onconetix (NASDAQ:ONCO) Trading Up 7.7%

Shares of Onconetix, Inc. (NASDAQ:ONCOGet Free Report) were up 7.7% during mid-day trading on Wednesday . The stock traded as high as $0.17 and last traded at $0.17. Approximately 312,100 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 3,591,094 shares. The stock had previously closed at $0.16.

Onconetix Price Performance

The company has a fifty day moving average price of $0.18. The stock has a market capitalization of $3.12 million, a PE ratio of -0.15 and a beta of 3.38.

About Onconetix

(Get Free Report)

Onconetix, Inc, a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia.

See Also

Receive News & Ratings for Onconetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconetix and related companies with MarketBeat.com's FREE daily email newsletter.